Clinical Trials on Chemoradiotherapy

Total 63 results

Texas A&M University

Unknown

Nutrition Intervention During Chemotherapy

Cancer Patients Receiving Chemotherapy or Chemoradiotherapy

United States
Xiaoqin Luo

Recruiting

Nutrition and Cancer Outcomes in Shaanxi Chemoradiotherapy

Cancer | Clinical Outcomes | Oncology | Nutrition, Healthy | Chemoradiotherapy

China
Peking University

Not yet recruiting

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ

Gastroesophageal Junction Cancer | Chemoradiotherapy | PD-1
Fondazione Policlinico Universitario Agostino Gemelli...
Viewray Inc.

Unknown

THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy (THUNDER2)

Locally Advanced Rectal Cancer | Pathological Complete Response | Neoadjuvant Chemoradiotherapy

Italy
Fudan University

Unknown

Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy (NSCLC)

NSCLC | Chemoradiotherapy | ctDNA

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Observational Study on the Patients With Rectal Cancer

Rectal Cancer | Surgery | Adjuvant Chemotherapy | Neoadjuvant Chemoradiotherapy | Adjuvant Chemoradiotherapy

China
Shanghai Jiao Tong University School of Medicine
Ruijin Hospital

Unknown

A Study for Short Preoperative Chemoradiotherapy for Resectable Rectal Carcinoma (IMRT)

Chemoradiotherapy

China
Zhongnan Hospital

Recruiting

Multi-mode Rehabilitation of Abdominal Tumor Patients Undergoing Concurrent Chemoradiotherapy

Concurrent Chemoradiotherapy;Nutrition；Multimodal Rehabilitation

China
Erasmus Medical Center

Active, not recruiting

Statistical Analysis Plan for the SANO-trial: Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Active Surveillance for Oesophageal Cancer (SANO)

Esophageal Cancer | Surgical Oncology | Neoadjuvant Chemoradiotherapy | Active Surveillance

Netherlands
Abramson Cancer Center at Penn Medicine

Recruiting

A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy | Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy

United States
Wuhan Union Hospital, China

Recruiting

Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction

Gastroesophageal Junction Cancer | PD-1 | Neoadjuvant Chemoradiotherapy

China
Fudan University
The First Affiliated Hospital with Nanjing Medical University; Hubei Cancer... and other collaborators

Unknown

Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer

Nutritional Status | Gastrointestinal Cancer | Chemoradiotherapy

China
WeiWei Xiao
Haplox Biotechnology Co., Ltd.

Recruiting

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

Minimal Residual Disease | Circulating Tumor DNA | Rectal Adenocarcinoma | Neoadjuvant Chemoradiotherapy

China
Jiangxi Provincial Cancer Hospital

Recruiting

Oral Probiotics on Radiation Enteritis Stage Ⅱ Induced by Pelvic Concurrent Chemoradiotherapy (probiotics)

Pelvic Cancer, Enteritis, Probiotics,Chemoradiotherapy

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer

Stomach Neoplasms | Radiotherapy, Intensity-Modulated | Chemoradiotherapy, Adjuvant

China
Zhongnan Hospital

Recruiting

Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer

Uterine Cervical Neoplasms | Angiogenesis | Chemoradiotherapy

China
China Medical University Hospital

Completed

A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients

Head and Neck Neoplasm | Chemoradiotherapy

Taiwan
Cancer Institute and Hospital, Chinese Academy...

Unknown

Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer

Gastric Cancer | Concurrent Chemoradiotherapy

China
Shanghai Zhongshan Hospital

Recruiting

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Surgery | Resectable Pancreatic Cancer | Adjuvant Chemoradiotherapy

China
Kangbuk Samsung Hospital

Recruiting

Non-OpeRative MANagement of Rectal Cancer Patients (NORMANDY)

Rectal Cancer | Chemoradiotherapy | Watch & Wait

Korea, Republic of
Fourth Affiliated Hospital of Guangxi Medical University

Recruiting

Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer

Uterine Cervical Neoplasms | Adjuvant Chemotherapy | Chemoradiotherapy

China
Corporacion Parc Tauli

Not yet recruiting

Prehabilitation in Rectal Cancer: During Neoadjuvant Therapy vs Preoperative (PREHAREC)

Rectal Cancer, Adenocarcinoma | Chemoradiotherapy

Spain
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer

Oligometastatic Disease | Immunotherapy | Esophagus Cancer | Chemoradiotherapy

China
Hangzhou Cancer Hospital

Completed

CCRT for Esophageal Cancer.

Esophageal Cancer | Paclitaxel | Concurrent Chemoradiotherapy | Oxaliplatin
Cancer Institute and Hospital, Chinese Academy...

Recruiting

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

Esophageal Cancer | Unresectable Malignant Neoplasm | Chemoradiotherapy | Nimotuzumab

China
Centre Hospitalier Universitaire, Amiens

Completed

Upfront Bevacizumab/témozolomide for Gliomastomas With Neurological Impairment (TEMOBEVA)

Chemoradiotherapy
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Chemoradiotherapy in Unresectable Esophageal Cancer

Esophageal Cancer | Unresectable Malignant Neoplasm | Chemoradiotherapy | Albumin-bound Paxlitaxel

China
Campus Bio-Medico University

Completed

Outcomes of Resection at Different Times Between the End of Neoadjuvant Treatment and Surgery

Surgery | Surgery--Complications | Rectal Tumor | Neoadjuvant Chemoradiotherapy
Fudan University
Harbin Medical University; Liaoning Tumor Hospital & Institute

Unknown

Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer

Adenocarcinoma | Neoadjuvant Therapy | Chemoradiotherapy | Rectal Neoplasm Malignant Carcinoma | Predictive Biomarkers

China
Cancer Institute and Hospital, Chinese Academy...

Completed

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

Stomach Neoplasms | Chemotherapy | Neoadjuvant Therapy | Chemoradiotherapy

China
Qilu Hospital of Shandong University

Not yet recruiting

Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM

Chemoradiotherapy | Colorectal Neoplasms Malignant | Lymph Node Excision

China
Chang Gung Memorial Hospital

Not yet recruiting

Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.

Head and Neck Neoplasms | Chemoradiotherapy | Stomatitis and Ulceration

Taiwan
Fudan University

Recruiting

Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical Cancer

Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor

China
West China Hospital

Recruiting

Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors (TNTCRT)

Chemoradiotherapy | Total Neoadjuvant Treatment | Local Advanced Rectal Cancer | High Risk Factors

China
Zhejiang Cancer Hospital

Recruiting

Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma (Neo-DRATEC)

Surgery | Esophageal Carcinoma | Neoadjuvant Chemoradiotherapy

China
LMU Klinikum
Department of Internal Medicine V, Thoracic Oncology Centre Munich, LMU Munich... and other collaborators

Recruiting

Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab (PRECISION)

Oncology | NSCLC, Stage III | Chemoradiotherapy | Biomarker | Durvalumab

Germany
Yunnan Cancer Hospital
Beijing Bethune Charitable Foundation

Recruiting

Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer (ESTIMATE)

Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer

China
Fudan University

Recruiting

Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer (NeoRacing)

Adenocarcinoma | Stomach Neoplasms | Gastrectomy | Neoadjuvant Therapy | Immunotherapy | Adjuvant Therapy | Chemoradiotherapy | Esophagogastric Junction Disorder

China
JIANYANG WANG
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting

The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patients

Esophageal Cancer | Thrombocytopenia | Concurrent Chemoradiotherapy | Intensity-modulated Radiation Therapy

China
Ruijin Hospital

Recruiting

Toripalimab Combined With Definitive CCRT for LACC Patients

Cervical Cancer | Immunotherapy | Chemoradiotherapy

China
Peking University

Recruiting

The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments

Gastric Cancer | Nutrition Aspect of Cancer | Neoadjuvant Chemotherapy | Systemic Inflammatory Response Syndrome (SIRS) | Neoadjuvant Chemoradiotherapy

China
Lei Li

Recruiting

NAC Followed by RH for the Treatment of LACC

Laparotomy | Laparoscopy | Locally Advanced Cervical Cancer | Neoadjuvant Chemotherapy | Adjuvant Therapy | Concurrent Chemoradiotherapy | Radical Hysterectomy | Objective Response | Systematic Chemotherapy

China
Anhui Provincial Hospital

Recruiting

Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer

Esophageal Squamous Cell Carcinoma | Chemoradiotherapy | Initial Inoperable

China
Anhui Provincial Hospital

Recruiting

Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma | Chemoradiotherapy | Immunonutrition | Inoperable

China
The First Affiliated Hospital with Nanjing Medical...

Not yet recruiting

Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer

To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
Tianjin Medical University Cancer Institute and...

Completed

To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy

Enteral Nutrition | Esophageal Squamous Cell Carcinoma | Chemoradiotherapy

China
The Netherlands Cancer Institute
Radboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaborators

Not yet recruiting

Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy (UPLAN-I)

Feasibility | Surgery | Safety | Chemoradiotherapy | Locally Advanced Non-Small Cell Lung Cancer | Cavitation Lung
Fudan University
Fujian Cancer Hospital; Jiangsu Cancer Institute & Hospital; Ningbo No.2 Hospital and other collaborators

Recruiting

Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)

Esophageal Squamous Cell Carcinoma | Survival | Chemoradiotherapy

China
Monopar Therapeutics

Terminated

Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. (VOICE)

Chemoradiotherapy-Induced Severe Oral Mucositis

United States, Spain, Germany, France, Puerto Rico
Sichuan Cancer Hospital and Research Institute

Active, not recruiting

PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial

Nasopharyngeal Carcinoma | Chemoradiotherapy | PD-1 Inhibitors

China

Clinical Trials on Chemoradiotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations